BioMed Research International · 2022 · 11 citations · 26 references
Life SciencesCell BiologyPharmacologyApoptosisInflammationNeurodegenerationAntioxidant DefenseNeurodegenerative DiseasesNeuroprotectionOxidative Damage To BiomoleculesOxidative StressReactive Oxygen SpeciesAmyloid-associated NeurotoxicityAmyloid-beta Induced ApoptosisAmyloid-beta-induced NeurotoxicityAntioxidant Defense MechanismsMalondialdehyde FormationNeurotoxicityNrf2 Pathway ActivationOxidative Stress Injury
Amyloid‐beta (A β ) peptide induces neurotoxicity through oxidative stress and inflammatory response. Brain deposition of a large amount of amyloid‐beta (A β ), in particular A β 42 , promotes the development of Alzheimer’s disease (AD). Maackiain is extracted from traditional Chinese medicine peony root and possesses antioxidative, antiosteoporosis, antitumor, and immunoregulatory effects. Whether Maackiain can reduce neurotoxicity caused by A β accumulation remains elusive. Herein, we found that Maackiain downregulated A β 42 ‐induced cell injury and apoptosis in PC12 cells. Moreover, Maackiain prevented A β 42 stimulation‐induced generation of oxidative stress and reduced A β 42 ‐caused impairment of mitochondrial membrane potential in PC12 cells. Maackiain increased the superoxide dismutase activity and decreased malondialdehyde content that was induced by A β 42 . Mechanistic studies showed that Maackiain increased intranuclear Nrf2 expression. Consistently, Nrf2 silencing by RNA interference weakened the protective role of Maackiain against A β exposure. In addition, calphostin C, a specific antagonist of protein kinase C, attenuated the promoting effects of Maackiain on Nrf2 nuclear translocation. Moreover, calphostin C attenuated the antioxidant and anti‐inflammatory capabilities of Maackiain in PC12 cells. Collectively, Maackiain promoted Nrf2 activation through the PKC signaling pathway, thus preventing PC12 cells from A β ‐induced oxidative stress and cell injury, suggesting that Maackiain is a potential drug for AD treatment.
26
Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue
Junxia Lu, Wei Qiang, Wai‐Ming Yau et al. · Cell · 2013 · 1.1K citations · Full text